Maida Anthony E III

Avg. Two Year Performance

67% Avg. Purchase Return
29% Compound
11% Avg. Sale Return
5% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return17%17%(10%)(21%)67%
Purchase Success Rate1 of 11 of 10 of 10 of 11 of 1
Average Sale Return< 1%10%13%39%11%
Sale Success Rate6 of 1510 of 1512 of 1513 of 158 of 15
Drugs » Biotechnology

CHIEF CLINICAL OFFICER, Director:

Holdings: 1.14M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Manufacturers - Major

Director:

Holdings: 29.61K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Metals and Mining » Industrial Metals & Minerals

Director:

Holdings: 100.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: 45.6K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--